BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24266914)

  • 1. Review of treatment options for nonalcoholic fatty liver disease.
    Corrado RL; Torres DM; Harrison SA
    Med Clin North Am; 2014 Jan; 98(1):55-72. PubMed ID: 24266914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan.
    Okanoue T; Umemura A; Yasui K; Itoh Y
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():153-62. PubMed ID: 21199527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of nonalcoholic steatohepatitis: an evidence-based approach.
    Mahady SE; George J
    Clin Liver Dis; 2012 Aug; 16(3):631-45. PubMed ID: 22824485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing nonalcoholic fatty liver disease: recommendations for family physicians.
    Grattagliano I; Portincasa P; Palmieri VO; Palasciano G
    Can Fam Physician; 2007 May; 53(5):857-63. PubMed ID: 17872748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of weight loss on nonalcoholic fatty liver disease.
    Rafiq N; Younossi ZM
    Semin Liver Dis; 2008 Nov; 28(4):427-33. PubMed ID: 18956298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pediatric nonalcoholic fatty liver disease/nonalcoholic steatohepatitis].
    Takahashi Y; Fukusato T; Inui A; Fujisawa T
    Nihon Rinsho; 2012 Oct; 70(10):1827-34. PubMed ID: 23198569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in pediatric nonalcoholic fatty liver disease.
    Mencin AA; Lavine JE
    Pediatr Clin North Am; 2011 Dec; 58(6):1375-92, x. PubMed ID: 22093857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic.
    Ismail MH
    Am J Med Sci; 2011 Jun; 341(6):485-92. PubMed ID: 21412139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery.
    Pardee PE; Lavine JE; Schwimmer JB
    Semin Pediatr Surg; 2009 Aug; 18(3):144-51. PubMed ID: 19573756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.
    Lebovics E; Rubin J
    Diabetes Metab Res Rev; 2011 Jul; 27(5):419-24. PubMed ID: 21425426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; MiezyƄska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease.
    Polyzos SA; Kountouras J; Zavos C; Deretzi G
    J Clin Gastroenterol; 2012 Apr; 46(4):272-84. PubMed ID: 22395062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatic steatosis : Differential diagnostics and current aspects].
    Canbay A; Gerken G; Bechmann LP
    Internist (Berl); 2016 Sep; 57(9):879-92. PubMed ID: 27510334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-alcoholic fatty liver disease in obese children and adolescents].
    Denzer C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):517-27. PubMed ID: 23529597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease: a challenge for pediatricians.
    Widhalm K; Ghods E
    Int J Obes (Lond); 2010 Oct; 34(10):1451-67. PubMed ID: 20838401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expert opinion on current therapies for nonalcoholic fatty liver disease.
    Della Corte C; Alisi A; Iorio R; Alterio A; Nobili V
    Expert Opin Pharmacother; 2011 Aug; 12(12):1901-11. PubMed ID: 21639814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease and bariatric surgery in adolescents.
    Holterman A; Gurria J; Tanpure S; DiSomma N
    Semin Pediatr Surg; 2014 Feb; 23(1):49-57. PubMed ID: 24491369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.